Background
Although cerebral metabolic changes during neonatal encephalopathy (NE) have been well characterised using magnetic resonance spectroscopy (MRS) in single-centre studies, the widespread effect of therapeutic hypothermia is less clear.
Objective
To describe patterns of brain injury in a prospective multi-centre cohort of infants with NE who had rescue hypothermic neuroprotection.
Design
After MRS harmonisation on 3T MR scanners (Phillips, GE, Siemens), at six participating sites we performed magnetic resonance imaging (MRI) and MRS (single-voxel PRESS, 15 x 15 × x 15 mm3 thalamic voxel, TR = 2s/TE = 288 ms) on infants <2 wks who had whole-body cooling for NE at any of the MARBLE centres. We used jMRUI to process MRS data and calculate metabolite peak-area ratios.
Results
Forty-three infants were recruited; 11(26%) had mild, 26(60%) moderate and 6(14%) had severe NE (<6h Sarnat staging). Moderate/severe basal ganglia and cortex were detected by MRI in 4(9%) and 1(2%) cases respectively, and 15(34%) had moderate/severe white matter injury. Thirteen (30%) had normal MRI.
Elevations in lactate (Lac)/N-acetylaspartate (NAA) were noted in 6(13%) cases, Lac/choline (Cho) in 5(11%) and Lac/ creatine (Cr) in 8(18%). MRS was normal in 28(65%) infants.
Abstract 8.8 Figure 1
Figure 1 displays metabolite peak-area ratios across clinical NE stages. Mean Lac ratios were higher and NAA ratios lower (p < 0.05) between severe and both mild and moderate NE, but not between mild and moderate groups
Conclusions
In this predominantly moderate NE cohort, white matter injury was most common, and the majority had normal MRS metabolite ratios. Ongoing work seeks to establish whether these brain injury patterns are characteristic in the cooling therapy era.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.